Twenty Years Future Perspectives of Cardiovascular Regenerative Medicine

At the year of 2000, the Japanese Government started so-called The Millennium Project to facilitate the research projects of the Genome Medicine and Regenerative Medicine. During the course of this project, Prof. Yamanaka invented the induced pluripotent stem (iPS) cells, which resulted in the Nobel Prize for Physiology or Medicine. Now, modified iPS cells are under a clinical trial for the treatment of aged-related macular degeneration. Now a days, there are remarkable development of regenerative medicine in the cardiovascular field too. Not only iPS cell-mediated regeneration research but also many other basic and clinical researches using somatic stem cells and genes are on going. Abstracts of this symposium are open for applicants who are engaged in the basic and/or clinical researches of cardiovascular regenerative medicine. The selected applicants are encouraged to present their current research results as well as 20-years future perspectives of their research topics.